# Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

> **NCT01539707** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 14 (actual)

## Conditions studied

- Overactive Bladder
- Neurogenic Detrusor Overactivity

## Interventions

- **DRUG:** Solifenacin succinate suspension 5 mg

## Key facts

- **NCT ID:** NCT01539707
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-13
- **Primary completion:** 2012-08-13
- **Final completion:** 2012-08-13
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539707, "Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01539707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*